Fayez Sarofim & Co Portfolio holdings
AUM
$41.7B
1-Year Return
15.12%
This Quarter Return
-5.91%
1 Year Return
+15.12%
3 Year Return
+67.65%
5 Year Return
+130.07%
10 Year Return
+262.45%
AUM
$25.3B
AUM Growth
-$2.07B
(-7.6%)
Cap. Flow
-$298M
Cap. Flow
% of AUM
-1.18%
Top 10 Holdings %
Top 10 Hldgs %
42.44%
Holding
294
New
5
Increased
61
Reduced
122
Closed
16
Top Buys
| 1 |
Novo Nordisk
NVO
|
$44.9M |
| 2 |
Exxon Mobil
XOM
|
$17.1M |
| 3 |
HES
Hess
HES
|
$13.3M |
| 4 |
Visa
V
|
$11.5M |
| 5 |
EOG Resources
EOG
|
$7.04M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$49.1M |
| 2 |
TotalEnergies
TTE
|
$44.3M |
| 3 |
Kellanova
K
|
$38.6M |
| 4 |
Apple
AAPL
|
$36.4M |
| 5 |
Organon & Co
OGN
|
$26.1M |
Sector Composition
| 1 | Technology | 21.28% |
| 2 | Consumer Staples | 19.28% |
| 3 | Financials | 18.16% |
| 4 | Energy | 12.21% |
| 5 | Healthcare | 11.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Gilead Sciences
GILD
$140B
| $2.78M | 0.01% |
44,985
-971
| -2% | -$59.9K |
|
127
British American Tobacco
BTI
$121B
| $2.74M | 0.01% |
77,250
| – | – |
|
128
Oracle
ORCL
$626B
| $2.58M | 0.01% |
42,291
-1,770
| -4% | -$108K |
|
129
Oneok
OKE
$46.8B
| $2.57M | 0.01% |
50,177
| – | – |
|
130
Crown Castle
CCI
$41.6B
| $2.57M | 0.01% |
17,742
-268
| -1% | -$38.7K |
|
131
Equinix
EQIX
$75.2B
| $2.52M | 0.01% |
4,423
| – | – |
|
132
Fox Class A
FOXA
$27.1B
| $2.5M | 0.01% |
81,313
-35,522
| -30% | -$1.09M |
|
133
Deere & Co
DE
$128B
| $2.3M | 0.01% |
6,887
+600
| +10% | +$200K |
|
134
Norfolk Southern
NSC
$62.8B
| $2.23M | 0.01% |
10,644
-200
| -2% | -$41.9K |
|
135
Danaher
DHR
$143B
| $2.15M | 0.01% |
9,402
+339
| +4% | +$77.6K |
|
136
Paychex
PAYX
$49.4B
| $2.08M | 0.01% |
18,521
-307
| -2% | -$34.4K |
|
137
Emerson Electric
EMR
$74.9B
| $2M | 0.01% |
27,362
-2,629
| -9% | -$192K |
|
138
Biogen
BIIB
$20.5B
| $1.98M | 0.01% |
7,413
| – | – |
|
139
Cisco
CSCO
$269B
| $1.94M | 0.01% |
48,557
-126,277
| -72% | -$5.05M |
|
140
Thermo Fisher Scientific
TMO
$185B
| $1.89M | 0.01% |
3,718
+1,378
| +59% | +$699K |
|
141
CSX Corp
CSX
$60.9B
| $1.88M | 0.01% |
70,404
| – | – |
|
142
Fox Class B
FOX
$24.6B
| $1.85M | 0.01% |
64,857
-31,249
| -33% | -$891K |
|
143
CVS Health
CVS
$93.5B
| $1.84M | 0.01% |
19,262
-418
| -2% | -$39.9K |
|
144
Ralph Lauren
RL
$19.4B
| $1.78M | 0.01% |
20,900
| – | – |
|
145
International Flavors & Fragrances
IFF
$16.8B
| $1.73M | 0.01% |
19,094
+75
| +0.4% | +$6.81K |
|
146
General Mills
GIS
$26.5B
| $1.66M | 0.01% |
21,622
+213
| +1% | +$16.3K |
|
147
Lowe's Companies
LOW
$148B
| $1.65M | 0.01% |
8,793
-1,980
| -18% | -$372K |
|
148
Tesla
TSLA
$1.09T
| $1.65M | 0.01% |
6,213
-618
| -9% | -$164K |
|
149
Freeport-McMoran
FCX
$66.1B
| $1.64M | 0.01% |
60,140
+30
| +0% | +$820 |
|
150
Regeneron Pharmaceuticals
REGN
$60.1B
| $1.62M | 0.01% |
2,350
| – | – |
|